WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Jennifer Loh, MD, explains the results of the SAHARA trial comparing TearCare and Restasis for treating dry eye disease.
The multicenter randomized trial showed both the TearCare system (Sight Sciences) and Restasis (cyclosporine ophthalmic emulsion 0.05%, Allergan) improved tear breakup time and Ocular Surface Disease Index scores after 6 months.
“TearCare did prove better at improving tear breakup time in patients, which makes sense since TearCare is indicated for the treatment of patients with dry eye